2019 cohort | 2020 cohort | |
---|---|---|
HAI | 14 (100) | 45 (100) |
Device-related HAI | ||
VAP | 0 (0.0) | 17 (37.8) |
CRBSI | 1 (7.1) | 0 (0.0) |
CAUTI | 1 (7.1) | 10 (22.2) |
BUO | 12 (85.8) | 14 (31.1) |
Clostridium difficile infection | 0 (0.0) | 2 (4.4) |
Surgical site infection | 0 (0.0) | 1 (2.2) |
Healthcare-associated pneumonia | 0 (0.0) | 1 (2.2) |
Microorganism | 19 (100) | 62 (100) |
Acinetobacter baumannii | 6 (31.6) | 18 (29.0) |
Candida albicans or parapsilosis | 0 (0.0) | 6 (9.7) |
Clostridium difficile | 0 (0.0) | 2 (3.2) |
Enterobateriaceae | 3 (15.8) | 9 (14.5) |
Enterococci | 6 (31.6) | 3 (4.8) |
Klebsiella pneumoniae | 3 (15.8) | 9 (14.5) |
Pseudomonas aeruginosa | 1 (5.3) | 5 (8.1) |
Staphylococcus aureus | 0 (0.0) | 2 (3.2) |
Coagulase Negative Staphylococci | 0 (0.0) | 8 (12.9) |